IIM
GILD icon

Ivory Investment Management’s Gilead Sciences GILD Stock Holding History

Ivory Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-67,045
Closed -$5.05M – 34
2018
Q1 		$5.05M Buy
+67,045
New +$5.33M 0.31% 51
2013
Q3 		– Sell
-21,770
Closed -$1.12M – 182
2013
Q2 		$1.12M Buy
+21,770
New +$1.13M 0.05% 137

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ivory Investment Management's GILD Position: Q2 2018 in Review

Ivory Investment Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 67,045 shares — an estimated $5.05M sold.

Ivory Investment Management first reported a position in GILD in Q2 2013 and held it in 2 quarters. The position peaked at $5.05M in Q1 2018. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Ivory Investment Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Ivory Investment Management sold 67,045 Gilead Sciences shares in Q2 2018, an estimated $5.05M.
  • Ivory Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 2 quarters.
  • Ivory Investment Management's Gilead Sciences position peaked at $5.05M in Q1 2018.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Ivory Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.